Anna Kathy Aman

Array ( [id] => 4746239 [patent_doc_number] => 20080090841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'METHODS OF ENHANCING MUCOSAL HYDRATION AND MUCOSAL CLEARANCE BY TREATMENT WITH SODIUM CHANNEL BLOCKERS AND OSMOLYTES' [patent_app_type] => utility [patent_app_number] => 11/851803 [patent_app_country] => US [patent_app_date] => 2007-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16894 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20080090841.pdf [firstpage_image] =>[orig_patent_app_number] => 11851803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4670539 [patent_doc_number] => 20080045599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Method for Increasing the Bioavailability of the Active Form of S-[2-([[1-(2-Ethylbutyl)Cyclohexyl]Carbonyl] Amino)Phenyl] 2-Methylpropanethioate' [patent_app_type] => utility [patent_app_number] => 11/847085 [patent_app_country] => US [patent_app_date] => 2007-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6789 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045599.pdf [firstpage_image] =>[orig_patent_app_number] => 11847085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4827146 [patent_doc_number] => 20080125489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Methods and compositions for the treatment and prevention of lung disease' [patent_app_type] => utility [patent_app_number] => 11/897026 [patent_app_country] => US [patent_app_date] => 2007-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4243 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20080125489.pdf [firstpage_image] =>[orig_patent_app_number] => 11897026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8458134 [patent_doc_number] => 08293803 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-23 [patent_title] => 'Retinoid compounds and their use' [patent_app_type] => utility [patent_app_number] => 12/439510 [patent_app_country] => US [patent_app_date] => 2007-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 13139 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12439510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4433147 [patent_doc_number] => 07897623 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-01 [patent_title] => 'ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/845597 [patent_app_country] => US [patent_app_date] => 2007-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29078 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/897/07897623.pdf [firstpage_image] =>[orig_patent_app_number] => 11845597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296226 [patent_doc_number] => 20100160393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'CRYSTAL FORM OF EPOTHILONE B AND USE IN PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/376973 [patent_app_country] => US [patent_app_date] => 2007-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3540 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160393.pdf [firstpage_image] =>[orig_patent_app_number] => 12376973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6493971 [patent_doc_number] => 20100093717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/310150 [patent_app_country] => US [patent_app_date] => 2007-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 45370 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093717.pdf [firstpage_image] =>[orig_patent_app_number] => 12310150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 338080 [patent_doc_number] => 07504422 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-17 [patent_title] => 'Polyamine compounds' [patent_app_type] => utility [patent_app_number] => 11/834204 [patent_app_country] => US [patent_app_date] => 2007-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15913 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/504/07504422.pdf [firstpage_image] =>[orig_patent_app_number] => 11834204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860397 [patent_doc_number] => 20080269247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Chemokine Inhibiting Piperazine Derivatives and Their Use to Treat Myocarditis' [patent_app_type] => utility [patent_app_number] => 11/834366 [patent_app_country] => US [patent_app_date] => 2007-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16838 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269247.pdf [firstpage_image] =>[orig_patent_app_number] => 11834366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4916347 [patent_doc_number] => 20080096948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'Serotonin antagonist compositions and methods for the local inhibition of pain and inflammation' [patent_app_type] => utility [patent_app_number] => 11/890273 [patent_app_country] => US [patent_app_date] => 2007-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 28082 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20080096948.pdf [firstpage_image] =>[orig_patent_app_number] => 11890273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 173894 [patent_doc_number] => 07659273 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-09 [patent_title] => 'Composition for accelerating bone fracture healing' [patent_app_type] => utility [patent_app_number] => 11/826921 [patent_app_country] => US [patent_app_date] => 2007-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14026 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/659/07659273.pdf [firstpage_image] =>[orig_patent_app_number] => 11826921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4553948 [patent_doc_number] => 07820711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'Uses of selective inhibitors of HDAC8 for treatment of T-cell proliferative disorders' [patent_app_type] => utility [patent_app_number] => 11/779743 [patent_app_country] => US [patent_app_date] => 2007-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 18860 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820711.pdf [firstpage_image] =>[orig_patent_app_number] => 11779743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5465808 [patent_doc_number] => 20090326008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'NF-kappa B Inhibitor' [patent_app_type] => utility [patent_app_number] => 12/309417 [patent_app_country] => US [patent_app_date] => 2007-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44019 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0326/20090326008.pdf [firstpage_image] =>[orig_patent_app_number] => 12309417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 142181 [patent_doc_number] => 07691873 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-06 [patent_title] => 'Preparation of pharmaceutical formulations' [patent_app_type] => utility [patent_app_number] => 12/309341 [patent_app_country] => US [patent_app_date] => 2007-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6280 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/691/07691873.pdf [firstpage_image] =>[orig_patent_app_number] => 12309341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5029044 [patent_doc_number] => 20070270491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'MICROBIOLOGICALLY SOUND AND STABLE SOLUTIONS OF GAMMA-HYDROXYBUTYRATE SALT FOR THE TREATMENT OF NARCOLEPSY' [patent_app_type] => utility [patent_app_number] => 11/777877 [patent_app_country] => US [patent_app_date] => 2007-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 28756 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270491.pdf [firstpage_image] =>[orig_patent_app_number] => 11777877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5534362 [patent_doc_number] => 20090234150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Use of ppar-alpha agonists to treat skeletal muscle wasting disorders' [patent_app_type] => utility [patent_app_number] => 12/309321 [patent_app_country] => US [patent_app_date] => 2007-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3264 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20090234150.pdf [firstpage_image] =>[orig_patent_app_number] => 12309321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4613364 [patent_doc_number] => 07989487 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => 'Estrogen receptor modulators and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/307565 [patent_app_country] => US [patent_app_date] => 2007-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6980 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/989/07989487.pdf [firstpage_image] =>[orig_patent_app_number] => 12307565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4559403 [patent_doc_number] => 07838513 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-23 [patent_title] => 'Anti-cancer therapy comprising an H2-blocker, at least one antiinflammatory agent and a cytotoxic agent' [patent_app_type] => utility [patent_app_number] => 12/307617 [patent_app_country] => US [patent_app_date] => 2007-07-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 8874 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/838/07838513.pdf [firstpage_image] =>[orig_patent_app_number] => 12307617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4894061 [patent_doc_number] => 20080103160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'Protein phosphatase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/823498 [patent_app_country] => US [patent_app_date] => 2007-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 23571 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20080103160.pdf [firstpage_image] =>[orig_patent_app_number] => 11823498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6496582 [patent_doc_number] => 20100010083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION' [patent_app_type] => utility [patent_app_number] => 12/305337 [patent_app_country] => US [patent_app_date] => 2007-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1887 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20100010083.pdf [firstpage_image] =>[orig_patent_app_number] => 12305337 [rel_patent_id] =>[rel_patent_doc_number] =>)